ProPhase Labs PRPH
OTC PRPH
$0.01 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProPhase Labs (PRPH) Asset Writedowns and Impairment (2014)

Updated

ProPhase Labs' Asset Writedowns and Impairment came in at $1.26 million for FY2025.

Analysis

ProPhase Labs (PRPH) Asset Writedowns and Impairment (2014) Analysis & Trends

Going back to FY2009, ProPhase Labs' Asset Writedowns and Impairment data covers 5 years.

  • Asset Writedowns and Impairment carries a four-year compound annual growth rate of 47.5% (FY2021 to FY2025).
  • The FY2025 figure represents the highest annual Asset Writedowns and Impairment since FY2014.
  • Per Business Quant, earlier years put Asset Writedowns and Impairment at -$78,000 in FY2022 and $267,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 ProPhase Labs 155,925.56 -390,074.44 226,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 3.58 Mn
API Access

ProPhase Labs Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=PRPH&period=max&api_key=YOUR_API_KEY